Accelerating Drug Discovery with Human-Relevant 3D Engineered Muscle Tissue Analysis SEATTLE, WA — Curi Bio, a leading developer of human stem cell-based platforms for drug discovery, today announced the commercial launch of the Mantarray™ platform for human-relevant 3D heart and skeletal engineered muscle tissue (EMT) contractility analysis. Curi’s Mantarray platform enables the discovery of new therapeutics […]
DRAGEN™ v4.0 brings greater accuracy, comprehensiveness, and efficiency to genomic analysis than ever before, unlocking the full potential of genomics to improve human health SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the release of Illumina DRAGEN™ v4.0, its most accurate and comprehensive secondary analysis platform. […]
Using Berkeley Lights’ high-throughput, functional screening service, Aanika BioSciences will now rapidly commercialize the propriety peptide to help improve and protect global food system EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced that […]
Brings differentiated miniaturization technology, scientific and engineering expertise, and enhanced ease-of-use capabilities to SomaLogic’s platform while expanding footprint to San Diego, CA BOULDER, Colo. and SAN DIEGO — SomaLogic (NASDAQ: SLGC), a leader in AI data-driven proteomics technology, today announced it entered into an agreement to acquire Palamedrix, Inc., an innovator in DNA nanotechnology. Palamedrix […]
New Facility Designed to Accelerate Growth of CRISPR-mediated Cell and Gene Therapies with Transformative Increase in Manufacturing Capacity REDWOOD CITY, Calif. – Synthego, the genome engineering company, announced today that the company has broken ground on a 20,000-square-foot manufacturing facility designed to accelerate translational and clinical research development timelines for cell and gene therapies to as […]
EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell and gene therapy and cell line development research. Since acquiring the Beacon Platform in October 2021, Otsuka Pharmaceutical scientists have […]
Dr. Matthias Essenpreis, Chief Technology Officer at Roche Diagnostics, complements the team of lino Biotech´s board members ZURICH — lino Biotech AG, a spin-out from Roche Diagnostics that has developed a reagent-free method for measuring molecular interactions in living cells or crude biological samples, welcomes Dr. Matthias Essenpreis as its new board member. With his […]
License allows Lepton, with their proprietary Castling Technology, to develop and commercialize products and services using CRISPR/Cas9 technology Dublin, Ireland and Zikhron Ya’akov, Israel: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Lepton Pharmaceuticals LTD (‘Lepton”). This is a non-exclusive licensing agreement granting Lepton access to the ERS CRISPR/Cas9 patent […]
Carlsbad, CA – Argonaut Manufacturing Services (‘Argonaut’), a contract manufacturing organization (CMO) serving the biopharma, life sciences, and molecular diagnostics industries, today announced the launch of BioFuseTM* Sample Prep device. BioFuse is a disposable cartridge solution that enables seamless integration of lyophilized reagents, sample filtration, and removal of pipetting steps to greatly simplify complex assay workflows. BioFuse requires no […]
EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Mehul Joshi has been named chief financial officer (CFO), effective immediately. “We are excited to have Mehul join Berkeley Lights and further strengthen our executive leadership team,” said Siddhartha Kadia, Ph.D., chief executive officer of Berkeley Lights. “Mehul […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
